What is Neulasta Onpro ?

Neulasta Onpro (pegfilgrastim) is a leukocyte growth factor used to reduce the risk of infection in cancer patients by boosting white blood cell counts. The medication is administered via a unique, needle-free on-body injector, which automatically delivers the dose approximately 27 hours after chemotherapy treatment. This method offers the convenience of not needing a return visit to the clinic for injection.

• Trouble breathing or fast breathing
• Swelling in your face, ankles, or feet
• Lightheadedness, dizziness, fainting
• Skin redness, blisters, or sores, red or purple spots on your skin
• Fever, chills, cough, sore throat, body aches, back or stomach pain
• Decrease in how much or how often you urinate, red or dark brown urine, lower back or side pain
• Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
• Unusual bleeding, bruising, tiredness, or weakness
• Pain in your left side or shoulder, or feeling unusually full

• Unusual bleeding, bruising, tiredness, or weakness
• Trouble breathing or fast breathing
• Keep all medicine out of the reach of children. Never share your medicine with anyone.
• Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
• Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results.
• This medicine lowers the number of certain blood cells, so you may bleed or bruise more easily. Be careful to avoid injuries.
• On-body Injector (OBI) for Neulasta®: Keep the injector at least 4 inches away from electrical equipment, including cell or cordless phones, microwaves, and other appliances.Do not use hot tubs or saunas while you are wearing the injector. Do not expose the injector to sunlight. Do not sleep on the injector. Call your doctor if the injector comes off before or during a dose.Keep the injector dry at least 3 hours before the dose is scheduled to start. This will help you notice any leaks. Call your doctor if the bandage becomes wet or the medicine is dripping.The injector is programmed to deliver your dose about 27 hours after it is placed on your skin. It will take about 45 minutes for the dose to be given. Avoid activities, including driving and traveling, that may interfere with the injector 1 hour before the dose starts, while it is being given, and for at least 1 hour afterward.You should avoid airport X-ray scans and request a manual pat down instead.You should avoid sleeping on the OBI for Neulasta® or applying pressure on the OBI for Neulasta®. Doing so may prevent the OBI from working properly.You should avoid getting body lotions, creams, oils, and cleaning agents near the OBI for Neulasta® as these products may loosen the adhesive that holds the OBI into your body.
• This medicine may cause the following problems:Spleen problemsLung problems (including acute respiratory distress syndrome)Kidney problemsCapillary leak syndromeBlood or bone marrow problems (including myelodysplastic syndrome and acute myeloid leukemia) in patients with breast or lung cancerAortitis (inflammation of the aorta, the largest artery in the body)
• Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, lung disease, breathing problems, or sickle cell disease. Tell your doctor if you have an allergy to acrylic adhesives or latex.